Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 504-507

  Advani, Anjali S ^a   Gibson, Sarah ^b   Douglas, Elizabeth ^b   Diacovo, Julia ^b   Elson, Paul ^b   Kalaycio, Matt ^a   Copelan, Ed ^a   Sekeres, Mikkael ^a   Sobecks, Ronald ^a   Sungren, Shawnda ^a   Lagoo, Anand ^c   Rizzieri, David ^c   Hsi, Eric ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acetylation; Acute lymphocytic leukaemia; Histone; Prognosis; Relapse

Indexed keywords

CYTARABINE; HISTONE DEACETYLASE INHIBITOR; HISTONE H4;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY;

ACETYLATION; ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HISTONES; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79954990342     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08607.x     Document Type: Article

References (8)

1. Advani, A.S., Gibson, S.E., Douglas, E., Jin, T., Zhao, X., Malaysia, M., Copelan, E., Sobecks, R., Sekeres, M., Sungren, S. & Hsi, E. (2010a) Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukaemia (ALL) patients. BMC Cancer, 10, 387-394.
2. Advani, A.S., Gundacker, H.M., Sala-Torra, O., Radich, J.P., Lai, R., Slovak, M.L., Lancet, J.E., Coutre, S.E., Stuart, R.K., Mims, M.P., Stiff, P.J. & Appelbaum, F.R. (2010b) Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia. British Journal of Haematology, 151, 430-434.
3. Elsheikh, S.E., Green, A.R., Rakha, E.A., Powe, D.G., Ahmed, R.A., Collins, H.M., Soria, D., Garibaldi, J.M., Paish, C.E., Ammar, A.A., Grainge, M.J., Ball, G.R., Abdelghany, M.K., Martinez-Pomares, L., Heery, D.M. & Ellis, I.O. (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69, 3802-3809.
4. Fielding, A.K., Richards, S.M., Chopra, R., Lazarus, H.M., Litzow, M.R., Buck, G., Durrant, I.J., Luger, S.M., Marks, D.I., Franklin, I.M., McMillan, A.K., Tallman, M.S., Rowe, J.M. & Goldstone, A.H. (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL): MRC UKALL12/ECOG 2993 study. Blood, 109, 944-950.
5. Moreno, D.A., Scrideli, C.A., Cortez, M.A., de Paula Queiroz, R., Valera, E.T., da Silva Silveira, V., Yunes, J.A., Brandalise, S.R. & Tone, L.G. (2010) Differential expression of HDAC3, HDAC7, and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 150, 665-673.
6. Scuto, A., Kirschbaum, M., Kowolik, C., Kretzner, L., Juhasz, A., Atadja, P., Pullarkat., V., Bhatia, R., Forman, S., Yen, Y. & Jove, R. (2008) The novel histone deacetylase inhibitor, LBH489, induces expression of DNA damage response genes and apoptosis in Ph-acute lymphoblastic leukemia cells. Blood, 15, 5093-5100.
7. Tzao, C., Guang-Huan, S., Tung, H.-J., Hsu, H.-S., Hsu, W.-H., Wang, Y.-C., Chen, Y.-L. & Lee, S.-C. (2006) Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected oesophageal squamous cell carcinoma. Annals of Thoracic Surgery, 82, 396-401.
8. Wetzler, M., Dodge, R.K., Mrozek, K., Carroll, A.J., Tantravahi, R., Block, A.W., Pettenati, M.J., Le Beau, M.M., Frankel, S.R., Stewart, C.C., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. & Bloomfield, C.D. (1999) Prospective analysis in adult acute lymphoblastic leukaemia: the Cancer and Leukemia Group B experience. Blood, 93, 3983-3993.